semaglutide oral fda approval US accepts Novo Nordisk's application for Wegovy for weight loss Novo Nordisk's weight-loss pill wins

If your weekly dose is 5 mg and you split it into two injections, each injection should be 2.5 mg

Yong C, Stewart GD, Frezza C

Free GSH administered intravenously is rapidly degraded by the organs that contain the enzyme -glutamyl transpeptidase (GT)

Nausea is the most frequently reported side effect, affecting 40 to 50 percent of patients at some point during treatment, typically during dose escalation

Mayo Clinic Health Matters Podcast (March 2026) on GLP-1 weight loss medications covering side effects, nutritional considerations, muscle loss, and what patients should discuss with their doctors

Attach a new needle and, if it is a new pen, perform the flow check (priming) per the instructions